Literature DB >> 11302652

A 10-year follow-up review of patients who underwent Leksell's posteroventral pallidotomy for Parkinson disease.

M I Hariz1, A T Bergenheim.   

Abstract

OBJECT: The clinical condition of patients with Parkinson disease (PD) who had undergone posteroventral pallidotomy (PVP) between 1985 and 1990 was evaluated at a mean of 10 years postsurgery. These patients were part of a larger series described in the first paper on Leksell's PVP that was published in 1992.
METHODS: Thirteen consecutive patients who had undergone pallidotomy at the University Hospital of Northern Sweden were tracked. Hospital and clinic records that had been updated regularly by the patients' various neurologists, geriatricians, and other clinicians were reviewed. Emphasis was placed on assessing the evolution of PD symptoms after surgery, and changes in the general health and social condition of the patients. The mean follow-up duration was 10.5 years (range 3-13.5 years). Five patients underwent a total of seven subsequent surgeries for their PD, 4 months to 11 years after the initial pallidotomy. The mean Hoehn and Yahr stage was 3 at the first surgery and 3.7 at the last follow-up review (p < 0.005). Dosages of levodopa and dopamine agonists were increased in all patients, without recurrence or induction of dyskinesias contralateral to the pallidotomy. Contralateral tremor, if it was initially controlled by surgery, remained improved. However, most patients exhibited a gradual recurrence of akinesia and an increase in gait freezing. Cognitive decline and presentation with diseases unrelated to PD were not uncommon.
CONCLUSIONS: The long-term effect of PVP on dyskinesias was not only curative but also appeared to be prophylactic. Contralateral tremor was improved in the majority of patients, although additional surgeries for PD were needed in some patients. Further progression of axial and akinetic symptoms, and an eventual decline in cognition together with other concomitant illnesses, contributed to increased disability in several patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302652     DOI: 10.3171/jns.2001.94.4.0552

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

1.  Surgery for movement disorders.

Authors:  Ralph Gregory
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

Review 2.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

3.  Post-stroke totally recovery of tremor in a patient with Parkinson's disease.

Authors:  Halil Onder; Esen Saka
Journal:  Neurol Sci       Date:  2017-02-24       Impact factor: 3.307

4.  Pallidotomy: A "Phoenix the Bird" of Surgery for Parkinson's Disease?

Authors:  Marwan Hariz
Journal:  Mov Disord Clin Pract       Date:  2022-01-26

5.  Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease.

Authors:  Adriana M Strutt; Eugene C Lai; Joseph Jankovic; Farah Atassi; Elizabeth M Soety; Harvey S Levin; Robert G Grossman; Michele K York
Journal:  Surg Neurol       Date:  2008-06-02

Review 6.  What happened to posteroventral pallidotomy for Parkinson's disease and dystonia?

Authors:  Robert E Gross
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

7.  Stereotactic radiosurgery for movement disorders.

Authors:  Leonardo Frighetto; Jorge Bizzi; Rafael D'Agostini Annes; Rodrigo Dos Santos Silva; Paulo Oppitz
Journal:  Surg Neurol Int       Date:  2012-01-14

Review 8.  Surgical Treatment of Parkinson's Disease: Devices and Lesion Approaches.

Authors:  Vibhash D Sharma; Margi Patel; Svjetlana Miocinovic
Journal:  Neurotherapeutics       Date:  2020-10-28       Impact factor: 7.620

9.  Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.

Authors:  J Guridi; R González-Redondo; J A Obeso
Journal:  Parkinsons Dis       Date:  2012-10-17

Review 10.  Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

Authors:  Jean-François Daneault; Benoit Carignan; Abbas F Sadikot; Michel Panisset; Christian Duval
Journal:  BMC Med       Date:  2013-03-20       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.